|
125
|
Safety Signal of Colistin and Risk of Stevens - Johnson Syndrome
|
|
Signal
|
|
|
124
|
Safety Signal of Ciclosporin and Risk of Respiratory Failure
|
|
Signal
|
|
|
123
|
Safety Signal of Secukinumab and the Risk of Facial Paralysis
|
|
Signal
|
|
|
122
|
Safety Signal of Rituximab and the Risk of Increased Aspartate Aminotransferase (AST)
|
|
Signal
|
|
|
121
|
Safety Signal of Dutasteride and the Risk of Diabetes Mellitus
|
|
Signal
|
|
|
120
|
Safety Signal of Olaparib and the Risk of Pneumocystis Jirovecii Pneumonia
|
|
Signal
|
|
|
119
|
Safety Signal of Pembrolizumab and the Risk of Cholestasis
|
|
Signal
|
|
|
118
|
Safety Signal of Secukinumab and the Risk of Erectile Dysfunction
|
|
Signal
|
|
|
117
|
Safety Signal of Dulaglutide and the Risk of Dysgeusia
|
|
Signal
|
|
|
116
|
Safety Signal of Dulaglutide and the Risk of Arthralgia
|
|
Signal
|
|
